Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monia Lenzi

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|December 22, 2020
Novel Psychoactive Phenethylamines: Impact on Genetic MaterialVeronica Cocchi, Sofia Gasperini, Patrizia Hrelia, et al.
Mutation Research|July 18, 2006
Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutationsCarmela Fimognari, Michael Nüsse, Monia Lenzi, et al.
Mutation Research|October 9, 2008
RNA as a new target for toxic and protective agentsCarmela Fimognari, Piero Sestili, Monia Lenzi, et al.
Biomolecules|October 27, 2022
6-(Methylsulfonyl) Hexyl Isothiocyanate: A Chemopreventive Agent Inducing Autophagy in Leukemia Cell LinesVeronica Cocchi, Beatriz Jávega, Sofia Gasperini, et al.
International Journal of Molecular Sciences|June 13, 2025
New Synthetic Opioids: What Do We Know About the Mutagenicity of Brorphine and Its Analogues?Monia Lenzi, Sofia Gasperini, Sabrine Bilel, et al.
Plos One|April 28, 2012
Sulforaphane potentiates RNA damage induced by different xenobioticsCarmela Fimognari, Monia Lenzi, Piero Sestili, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 1, 2012
Metabolic and toxicological considerations of botanicals in anticancer therapyCarmela Fimognari, Lorenzo Ferruzzi, Eleonora Turrini, et al.
Oncotarget|January 18, 2018
6-(Methylsulfonyl) hexyl isothiocyanate as potential chemopreventive agent: molecular and cellular profile in leukaemia cell linesMonia Lenzi, Veronica Cocchi, Marco Malaguti, et al.
Mutation Research|June 1, 2010
Sulforaphane induces DNA single strand breaks in cultured human cellsPiero Sestili, Marco Paolillo, Monia Lenzi, et al.
Pharmaceutics|February 25, 2023
Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and NanospermidineLucrezia Galassi, Martina Rossi, Pietro Lodeserto, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|December 22, 2020
Novel Psychoactive Phenethylamines: Impact on Genetic MaterialVeronica Cocchi, Sofia Gasperini, Patrizia Hrelia, et al.
Mutation Research|July 18, 2006
Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutationsCarmela Fimognari, Michael Nüsse, Monia Lenzi, et al.
Mutation Research|October 9, 2008
RNA as a new target for toxic and protective agentsCarmela Fimognari, Piero Sestili, Monia Lenzi, et al.
Biomolecules|October 27, 2022
6-(Methylsulfonyl) Hexyl Isothiocyanate: A Chemopreventive Agent Inducing Autophagy in Leukemia Cell LinesVeronica Cocchi, Beatriz Jávega, Sofia Gasperini, et al.
International Journal of Molecular Sciences|June 13, 2025
New Synthetic Opioids: What Do We Know About the Mutagenicity of Brorphine and Its Analogues?Monia Lenzi, Sofia Gasperini, Sabrine Bilel, et al.
Plos One|April 28, 2012
Sulforaphane potentiates RNA damage induced by different xenobioticsCarmela Fimognari, Monia Lenzi, Piero Sestili, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 1, 2012
Metabolic and toxicological considerations of botanicals in anticancer therapyCarmela Fimognari, Lorenzo Ferruzzi, Eleonora Turrini, et al.
Oncotarget|January 18, 2018
6-(Methylsulfonyl) hexyl isothiocyanate as potential chemopreventive agent: molecular and cellular profile in leukaemia cell linesMonia Lenzi, Veronica Cocchi, Marco Malaguti, et al.
Mutation Research|June 1, 2010
Sulforaphane induces DNA single strand breaks in cultured human cellsPiero Sestili, Marco Paolillo, Monia Lenzi, et al.
Pharmaceutics|February 25, 2023
Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and NanospermidineLucrezia Galassi, Martina Rossi, Pietro Lodeserto, et al.
Pageof 4